F. Jacob Seagull, Ph.D. is an Assistant Professor of Medical Education at the University of Michigan Medical School. His research interests include patient safety, human perception and preformance, technology design and implementation, and human factors.
Page not found
Raymond De Vries is co-author on a new publication in Academic Medicine, highlighting a successful model for collaboration which was developed in the early phases of a grant funded by the Bill & Melinda Gates Foundation nearly five years ago. The Collaborative Health Alliance for Reshaping Training, Education, and Research (CHARTER) project expanded the partnerships between the University of Michigan and several Ghanaian academic institutions to enhance health care provider education and build and/or increase research capacity. One of the early goals of the grant was to establish guiding principles for engagement through a Charter of Collaboration.
The August 2016 issue of AMA Journal of Ethics features commentaries by Christian Vercler, Lauren Smith, and Andrew Shuman.
"Is Consent to Autopsy Necessary? Cartesian Dualism in Medicine and Its Limitations"
Commentary by Megan Lane and Christian J. Vercler
"I Might Have Some Bad News: Disclosing Preliminary Pathology Results"
Commentary by Michael H. Roh and Andrew G. Shuman
"Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice"
Commentary by Virginia Sheffield and Lauren B. Smith
Darin Zahuranec’s survey study, “Variability in physician prognosis and recommendations after intracerebral hemorrhage” published in Neurology found that physicians vary substantially in ICH prognostic estimates and treatment recommendations. This study suggests that variability could have a profound effect on life and death decision-making and treatment for ICH.
Several CBSSM-affiliated faculty and alumni were co-authors: Angie Fagerlin, Meghan Roney, Andrea Fuhrel-Forbis, and Lewis Morgenstern.
Seeking feedback regarding developing a survey to assess the physicians' understanding of risks associated with proton pump inhibitors.Specifically, we are seeking input on the design of patient vignettes that include some randomized elements, and in the design of questions about providers quantitative estimates of PPI risk.